Schizoaffective Disorders Recruiting Phase 4 Trials for Lorcaserin (DB04871)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02796144MEtformin and Lorcaserin for WeighT Loss in SchizophreniaTreatment